Soares MO, Dumville JC, Ades AE, Welton NJ (2014) Treatment comparisons for decision making: facing the problems of sparse and few data
However, when aiming to achieve lower target glucose levels it has to be considered that people with SIHG often suffer from severe underlying disease (e.g., cancer), are in the perioperative care setting (e.g., recently transplanted patients or those requiring steroids as supportive therapy [31]), receive concomitant complex therapies (chemotherapy, immunosuppressants, antimicrobial therapy, etc.) and thus, might be prone to larger glucose fluctuations
Targeting small molecule delivery to the brain and spinal cord via intranasal administration of rabies virus glycoprotein (RVG29)-modified PLGA nanoparticles
If you're on a GLP-1, though, you might wonder whether your prescription gets rid of the need for food logging